InfuSystems Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was $0.08.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.62.
During the past 12 months, the average EBIT per Share Growth Rate of InfuSystems Holdings was 59.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 94.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 16.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for InfuSystems Holdings's EBIT per Share or its related term are showing as below:
INFU'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -45.6 Med: 16.3 Max: 94.3
Current: 94.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of InfuSystems Holdings was 94.30% per year. The lowest was -45.60% per year. And the median was 16.30% per year.
INFU's 3-Year EBIT Growth Rate is ranked better than 98.26% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs INFU: 94.30
InfuSystems Holdings (AMEX:INFU) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
InfuSystems Holdings EBIT per Share Related Terms
InfuSystems Holdings EBIT per Share Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a EBIT per Share of $0.62 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on InfuSystems Holdings and its competitors. According to the industry distribution chart, InfuSystems Holdings ranks #12 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 1.7%.
Is InfuSystems Holdings' EBIT per Share too high?
InfuSystems Holdings' current EBIT per Share is $0.62. The Medical Devices & Instruments industry median EBIT per Share is 9.50. InfuSystems Holdings' value of $0.62 is 93.5% below this industry median. Based on the distribution chart, InfuSystems Holdings ranks #12 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, InfuSystems Holdings has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' EBIT per Share compare to QTRX and LUCD?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #12 out of 690 companies for EBIT per Share. This places InfuSystems Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.50. InfuSystems Holdings' value of $0.62 is 93.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current EBIT per Share of $0.62 is 93.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current EBIT per Share is $0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $10.22 — trading 8.3% above its estimated fair value. The current EBIT per Share is $0.62 and 93.5% below the Medical Devices & Instruments industry median of 9.50. InfuSystems Holdings' overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current EBIT per Share is $0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued.
The current stock price of $10.22 is trading 8.3% above its estimated GF Value™ of $9.44.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
EBIT per Share: $0.62
GF Value™: $9.44 vs. price of $10.22 (8.3% above fair value)
Industry Position: 93.5% below the Medical Devices & Instruments median (#12 of 690)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
87GF Score
Get the complete analysis for INFU
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
